Combination therapy with paromomycin-associated stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulation
about
Combination of liposomal CpG oligodeoxynucleotide 2006 and miltefosine induces strong cell-mediated immunity during experimental visceral leishmaniasisTherapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c miceTh1-biased immunomodulation and therapeutic potential of Artemisia annua in murine visceral leishmaniasisImmunotherapeutic Potential of Eugenol Emulsion in Experimental Visceral LeishmaniasisDevelopments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects.Therapeutic and immunomodulatory activities of short-course treatment of murine visceral leishmaniasis with KALSOME™10, a new liposomal amphotericin B.Translational readthrough-promoting drugs enhance pseudoknot-mediated suppression of the stop codon at the Moloney murine leukemia virus gag–pol junction.Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar).Antimalarial Activity of Small-Molecule Benzothiazole Hydrazones.Immunomodulatory effects of antileishmanial drugs.Augmentation of antileishmanial efficacy of miltefosine in combination with tuftsin against experimental visceral leishmaniasis.Translating immune cell cross-talk into a treatment opportunity for visceral leishmaniasis.
P2860
Q27341915-D65006D4-F723-4721-ADE3-A61E52993469Q28477398-4EFE6DA2-B89F-4334-928C-D6DA65B2F5D3Q28542988-1BECDD8C-4C5E-4D12-83FB-66C6CBCBC471Q28552919-06574D7E-508F-4207-B9BA-4C889AF37171Q34328882-45C25F3A-95CA-4598-8671-42A620456A36Q35605511-C6A87383-AFAF-4413-AF56-591557B190CEQ38834522-17344504-5A69-494F-ACD0-7AA48EE0E3D2Q39599468-B5AACB9A-804C-4884-BE2C-948E3954D91FQ40690139-311BFDEC-7AB1-4B79-BEE8-111D1A0B63FCQ42256063-F28BE785-DDCA-4860-B004-7FAE88984724Q43561343-ABBAEB0C-B78B-4B0F-B678-2B40949E0A9BQ53088160-E5FC73B2-2919-463C-B650-1A1693F761B4
P2860
Combination therapy with paromomycin-associated stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulation
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Combination therapy with parom ...... gh Th1-biased immunomodulation
@en
Combination therapy with parom ...... gh Th1-biased immunomodulation
@nl
type
label
Combination therapy with parom ...... gh Th1-biased immunomodulation
@en
Combination therapy with parom ...... gh Th1-biased immunomodulation
@nl
prefLabel
Combination therapy with parom ...... gh Th1-biased immunomodulation
@en
Combination therapy with parom ...... gh Th1-biased immunomodulation
@nl
P2093
P2860
P356
P1476
Combination therapy with parom ...... gh Th1-biased immunomodulation
@en
P2093
Antara Banerjee
Manjarika De
P2860
P304
P356
10.1128/AAC.00524-10
P407
P577
2011-01-10T00:00:00Z